pharmaceutical-investing Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm
pharmaceutical-investing Aquestive Therapeutics Announces Regulatory Development for Anaphylm Sublingual Film and Provides Business Update
pharmaceutical-investing Aquestive Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
pharmaceutical-investing Aquestive Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
pharmaceutical-investing Aquestive Therapeutics to Participate in a Fireside Chat Hosted by Piper Sandler
pharmaceutical-investing Aquestive Therapeutics to Report Third Quarter 2025 Financial Results and Recent Business Highlights on November 5 and Host Conference Call on November 6 at 8:00 a.m. ET
pharmaceutical-investing Aquestive Therapeutics Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for Anaphylm
Saga Metals Acknowledges U.S. Strategic Critical Minerals Reserve "Project Vault" and Highlights Titanium's Strategic Importance to North American Defense Supply Chains
Blackrock Silver to Present at the Precious Metals and Critical Minerals Virtual Investor Conference on February 10th 2026
Oreterra Announces Engagement of Generation IACP Inc. to Provide Market Making Services and Engagement of Investing News Network to Provide Advertising and Investor Awareness Services
